David P Alldred

Biographic Data

ID6575632
NAMEDavid P Alldred
GIVEN NAMESDavid P
FAMILY NAMEAlldred
SIGNATUREALLDRED D P
AFFILIATIONSNIHR Yorkshire and Humber Patient Safety Research Collaboration Bradford UK
ORCID0000-0002-2525-4854
VERIFIEDYes
TOTAL WORKS8
TOTAL CITATIONS2
WORKS AS AUTHOR8
WORKS AS EDITOR0
FIRST PUBLICATION YEAR2020
LATEST PUBLICATION YEAR2025
H-INDEX1

  • Supporting Older People Living With Frailty to Self‐Manage Multiple Medicines

    Open AccessGiorgia Previdoli, Ruth Simms‐Ellis et al.ARTICLEHealth Expectations2025

    BACKGROUND: Older people face numerous challenges when managing multiple medicines. They are required to cope with complicated and changing medicines regimens and coordinate input from multiple health and social care professionals. When not well managed, medicines can cause harm, and older people are more susceptible to the impact of errors. Nevertheless, there is a lack of interventions addressing the multiple tasks required for them to manage p…

  • ‘It's a job to be done’. Managing polypharmacy at home

    Open AccessGiorgia Previdoli, David P Alldred et al.ARTICLEHealth Expectations2024

  • Co‐designing an intervention to improve the process of deprescribing for older people living with frailty in the United Kingdom

    Open AccessJonathan Silcock, Iuri Marques et al.ARTICLEHealth Expectations2023

    BACKGROUND: In older people living with frailty, polypharmacy can lead to preventable harm like adverse drug reactions and hospitalization. Deprescribing is a strategy to reduce problematic polypharmacy. All stakeholders should be actively involved in developing a person-centred deprescribing process that involves shared decision-making. OBJECTIVE: To co-design an intervention, supported by a logic model, to increase the engagement of older peopl…

  • A rapid review of interventions to improve medicine self‐management for older people living at home

    Open AccessGiorgia Previdoli, V‐Lin Cheong et al.ARTICLEHealth Expectations2023

  • Experiences of patients with heart failure with medicines at transition intervention

    Open AccessCatherine Powell, Hanif Ismail et al.ARTICLEHealth Expectations2022

    BACKGROUND: Medicines are often suboptimally managed for heart failure patients across the transition from hospital to home, potentially leading to poor patient outcomes. The Improving the Safety and Continuity Of Medicines management at Transitions of care programme included: understanding the problems faced by patients and healthcare professionals; developing and co-designing the Medicines at Transitions of care Intervention (MaTI); a cluster r…

  • Enhancing deprescribing

    Open AccessLinda Birt, David Wright et al.ARTICLEHealth & Social Care in the…2022Cited by: 1References: 2

    The English National Overprescribing Review identified that older people often take eight or more medicines a day. The report recommended pharmacists in primary care should take responsibility for addressing polypharmacy. Overprescribing is a safety concern in care homes as approximately half of older care home residents are prescribed at least one medicine that is unnecessary or now harmful. This predisposes them to adverse outcomes including ho…

  • Patients as qualitative data analysts

    Open AccessCatherine Powell, Hanif Ismail et al.ARTICLEHealth Expectations2021

    Background How to meaningfully partner with patients as data analysts remains obscure. A process evaluation of the ‘Improving the Safety and Continuity Of Medicines management at care Transitions’ (ISCOMAT) cluster randomised control trial of an intervention for improving medicines use for people living with heart failure is being conducted. The intervention includes patient held information on heart medicines and care, enhanced communication bet…

  • Everyone needs to understand each other’s systems”

    Open AccessKATHLEEN LANE, Catherine M Bond et al.ARTICLEHealth & Social Care in the…2020Cited by: 1References: 1

    The role of an innovative Pharmacist Independent Prescriber (PIP) for care homes to optimise medications has not been examined. We explored stakeholders' views on issues and barriers that the PIP might address to inform a service specification for the PIP intervention in older people's care homes. Focus groups (n = 72 participants) and semi-structured interviews (n = 13) undertaken in 2015 across four sites in the United Kingdom captured the view…